# StrokeAlarm Trial 2

Study · id `cardio:ct-nct05144932` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05144932](<https://clinicaltrials.gov/study/NCT05144932>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05144932

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT05144932. Allocation not applicable; no masking; primary purpose supportive care. Start 2022-01-01 (actual); primary completion 2025-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT05144932, source copy `cardio:ctgov-nct05144932-2024-03-12`, retrieved 2026-10-26)
- Started: 2022-01-01 (actual) (ClinicalTrials.gov record NCT05144932, source copy `cardio:ctgov-nct05144932-2024-03-12`, retrieved 2026-10-26)
- Primary completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT05144932, source copy `cardio:ctgov-nct05144932-2024-03-12`, retrieved 2026-10-26)
- Completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT05144932, source copy `cardio:ctgov-nct05144932-2024-03-12`, retrieved 2026-10-26)
- Countries: Sweden (ClinicalTrials.gov record NCT05144932, source copy `cardio:ctgov-nct05144932-2024-03-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05144932-2024-03-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: StrokeAlarm Trial 2
- Condition: Stroke
- Condition: Atrial Fibrillation
- Condition: TIA
- Intervention (Device): Stroke Alarm
- Lead sponsor: Region Skane
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Region Skane (`cardio:org-region-skane`)

## Provenance

Content hash: ede818bd9ca47298623439a854ed211f786e49b3ae710fdbd074ba6f2b513784
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
